Previously the Live Forever Club — same community, now with a sharper mission for life extension

AI skin cancer checks cut waiting times at Bradford NHS clinic

AI lets a Bradford clinic see a third more suspected skin cancer patients

05-Oct-2026

Key points from article :

An NHS clinic in Bradford says an artificial intelligence (AI) system for checking suspicious moles and skin lesions has cut waiting times and reduced unnecessary procedures. The dermatology team at St Luke's Hospital, part of Bradford Teaching Hospitals NHS Foundation Trust, began using the technology in April 2026, and staff now describe it as a potential "game changer".

The system, called DERM (Deep Ensemble for Recognition of Malignancy), was developed by the UK company Skin Analytics. A healthcare assistant takes three photographs of a lesion and uploads them, and the software analyses them within minutes. Patients whose lesions look harmless are given advice and discharged, while suspicious cases go straight to a specialist in a one-stop clinic. In Bradford, a clinician double-checks every image.

The trust says the clinic can now see 32 patients per session instead of 24, and the number of unnecessary biopsies has fallen by about 10%. Bradford receives around 5,000 urgent referrals for suspected skin cancer each year, yet only about 8%, or roughly 400 patients, turn out to have a malignant cancer. Quickly ruling out harmless lesions frees specialists to focus on the patients who need them most.

Skin Analytics says DERM is 99.9% accurate at ruling out melanoma, the most dangerous form of skin cancer. The National Institute for Health and Care Excellence (NICE) has conditionally recommended the technology for NHS use over three years while more evidence is gathered, and it is now used in around 40 NHS trusts. Bradford was the first trust in Yorkshire to adopt it.

The figures so far come from the trust and the manufacturer rather than an independent evaluation, and NICE's recommendation depends on further evidence of clinical and cost effectiveness. Not every AI flag means cancer: in one case, a mole the system marked as suspicious was judged likely to be benign by a specialist and will be removed and tested to confirm.

Mentioned in this article:

Click on resource name for more details.

NHS

UK National Health Service, publicly funded healthcare system in England

Skin Analytics

Research-led company working on skin cancer, provides teledermatology services

Topics mentioned on this page:
AI Diagnostics, Skin Cancer
AI skin cancer checks cut waiting times at Bradford NHS clinic
DoNotAge supplements affiliate link